Manningham locals participate in Australia’s largest ever disease prevention trial The ASPREE (ASPirin in Reducing Events in the Elderly) study – the largest ever disease prevention aspirin trial to take place in Australia – is celebrating the participation of 250 Manningham residents who have signed up to the trial. The study will test whether taking…
DetailsHave you seen the ASPREE Community Service Announcement with Sir Gus Nossal? We are delighted to have the support of such a high profile and highly respected researcher.
ASPREE would like to sincerely thank Gus Nossal and Australian TV networks for airing this CSA.
New research published in the New England Journal of Medicine has found that aspirin may block the growth of colorectal tumours that were known to have a specific gene mutation. Researchers affiliated with the Harvard Medical School reported that aspirin was associated with a prolonged life of patients with tumours that carried the mutated PIK3CA…
DetailsLeading cancer expert says recent study adds further support for a randomised clinical trial of aspirin for cancer prevention. New research published in Acta Obstetricia et Gynecologica Scandinavica, a journal of the Nordic Federation of Societies of Obstetrics and Gynecology, showed regular aspirin may decrease the risk of ovarian cancer. Ovarian Cancer is the ninth most…
Details
Federal Minister launches ASPREE in Adelaide The Hon Mark Butler MP, Minister for Mental Health and Ageing described the ASPREE study as an incredibly important piece of medical research during the official opening of the new clinical centre in Adelaide on September 21, 2012. He said the ASPREE study ticked a number of boxes: it addressed…
Details
Humble hero or hidden villain? The ongoing story of aspirin’s powers. by Professor Andrew Tonkin The humble aspirin has a remarkable history dating back to ancient Egyptian times when the bark of weeping willow (which contains salicin from which the aspirin formulation is derived) was found to have anti-inflammatory properties. And Hippocrates wrote about the…
Details
A Lovely Surprise
We love to hear from ASPREE participants. Your letters share thoughtful suggestions, compliments, comments and questions.
And then there are notes, like this one “Wishing you and yours a happy day.” returned with an ALSOP questionnaire, which simply brightens our day.
Thank you.
Bendigo’s postive and active ageing newsetter ‘Zoom’, features a story on ASPREE’s Lynn O’Neill and her incredible knitting skills this month. Lynn moved from Melbourne to Central Victoria in late 2010, a move she hasn’t regretted. Read her story from Issue 3 Spring 2012 here: There was a time when local nurse Lynn O’Neill’s dream…
Details
Congratulations to the hardworking Biobank team and to 5,000 wonderful ASPREE participants. Together, we’ve reached the half way mark on this very important, world first, Healthy Ageing Biobank study. Many Biobank participants will be familiar with the ASPREE BioBus, a specially fitted mobile laboratory that enables participants in regional and rural Victoria, NSW and Tasmania to participate…
DetailsOver 150 people marked the 500th participant in the ACT to be enrolled in the healthy ageing study, ASPREE (ASPirin in Reducing Events in the Elderly) at a morning tea in Canberra today. ASPREE, the largest ever primary prevention aspirin study in Australians aged 70 and over, is investigating whether aspirin can delay or prevent the…
Details© 2019 All Rights Reserved. • Monash University, Department of Epidemiology and Preventive Medicine | Disclaimer & Privacy